Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00151190 · ClinicalTrials.gov registry record · Phase 3

Community Diabetes Education Program Evaluation "Code Evaluation"

A Phase 3 study of Diabetes Mellitus, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 3
Development phase
180
Enrollment target
1
Study location

NCT00151190: Completed Phase 3 study of Diabetes Mellitus, sponsored by The University of Texas Health Science Center, Houston.

NCT00151190 is a Phase 3 study of Diabetes Mellitus that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 180 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00151190, a Phase 3 study of Diabetes Mellitus, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 3
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The study is intended to determine the effectiveness and efficiency of a community diabetes education program administered by a community health worker in a low-cost community clinic. We expect an improvement in overall glycemic control in the experimental group of at least 20%. We also expect to document improvement in diabetes self-management skills, quality of life and an increase in achievement of ADA standards of care4 in the experimental group.

Conditions Studied

Interventions

  • BEHAVIORAL Education for diabetes self-management

Study Locations (1)

Texas

  • Central Dallas Ministries Community Health Services Clinic - Dallas

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2005-04
Est. Completion 2006-08
Phase Phase 3

What the finished NCT00151190 record still lists

NCT00151190 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Education for diabetes self-management is the first listed.

NCT00151190 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00151190 about?

NCT00151190 is a clinical study titled "Community Diabetes Education Program Evaluation "Code Evaluation"". The study is intended to determine the effectiveness and efficiency of a community diabetes education program administered by a community health worker in a low-cost community clinic. We expect an improvement in overall glycemic control in the experimental group of at least 20%. We also expect to do...

What is the current status of trial NCT00151190?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2005-04. Estimated completion is 2006-08.

What conditions does trial NCT00151190 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00151190?

The interventions under investigation include: Education for diabetes self-management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00151190?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00151190 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00151190's enrollment target sits among peer trials

180 94th of 208 higher than 115 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00151190, the US trial registry maintained by the National Library of Medicine. NCT00151190 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.